# HYCAMTIN

NDC: 0078-0674
Generic name: topotecan hydrochloride
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20161221

FDA application: NDA020671

## Active ingredients

- TOPOTECAN HYDROCHLORIDE: 4 mg/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0674"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0674
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eeee060c-a9ec-423e-a374-8484009f8524